Our current case-control study, employing triallelic 5-HTTLPR genotypes and STin2, indicates that the SLC6A4 gene polymorphism is not associated with CAD susceptibility; however, smoking, as a non-genetic risk factor, is linked to increased risk CAD. The gene discussed is SLC6A4; the disease is coronary artery disorder.